Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trialAndreas Jahn, Patrick Schöffski, Christoph Burkart et al.|British Journal of Cancer|2008Cited by 87
Phase II Trial of Capecitabine and Oxaliplatin in Patients with Adeno- and Undifferentiated Carcinoma of Unknown PrimaryKatharina Schuette, G. Huebner, Gunnar Folprecht et al.|Oncology Research and Treatment|2009Cited by 20
Paclitaxel (P)/carboplatin (C) versus gemcitabine (G)/vinorelbine (V) in patients with adeno- or undifferentiated carcinoma of unknown primary (CUP) - A randomized prospective phase-II-trialG. Huebner, Hartmut Link, Silke Steinbach et al.|Journal of Clinical Oncology|2005Cited by 9
Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUPAlwin Krämer, Gunnar Folprecht, Karolin Trautmann et al.|British Journal of Cancer|2020Cited by 7
Paclitaxel/carboplatin with or without cetuximab for treatment of carcinoma with unknown primary (PACET-CUP): Results of a multi-center randomized phase II AIO trial.Alwin Krämer, Alexander Stein, G. Huebner et al.|Journal of Clinical Oncology|2019Cited by 2